Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
about
Gastric biomarkers: a global reviewMouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancerMechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancerMutation analysis of APC gene in gastric cancer with microsatellite instability.Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions.CDH1 mutations in gastric cancer patients from northern Brazil identified by Next- Generation Sequencing (NGS)A short guide to hereditary diffuse gastric cancer.Understanding the genetic basis of gastric cancer: recent advances.Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.A protein and mRNA expression-based classification of gastric cancer.E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas.Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.Expression of immunohistochemical markers according to histological type in patients with early gastric cancer.
P2860
Q26741859-FF7A2543-73E8-42F2-8D45-9C825361289FQ33518944-0E0E5D53-4D35-45A1-8F08-26BDEA8DE567Q33867088-8F064A8C-B028-4BFE-BCAE-2F345CB0664AQ34094855-AB91BD12-A978-4638-99C3-2B355280191EQ35077715-EAA1D4FE-82AC-4F8A-925C-EDCC4B5222ABQ36308958-2A8216A0-0F6A-4728-9F22-C84777F4588EQ36502563-8C22A6EE-440D-4CAD-88B6-2A90F81340E5Q37011917-8352083E-E905-40F8-8057-130A65AA7761Q37331082-6F238854-18CE-4A3F-8C2C-11C28A4C4ED3Q38014496-4CF7E59A-BF87-4709-9DDB-0734C59469D2Q38129925-94EC6CD4-85BB-4840-893D-B22E086D6B59Q39996922-E09F92E0-1B2D-44A3-A567-B689F06A6029Q40824215-B523521C-1AA8-45FC-AAE8-79F38A1E1035Q51822910-B7680107-52CD-4D5B-AF6A-EBAEA995224AQ53121949-D84B6018-1FE2-495A-95BB-5064F9327135Q53439664-4B7CAA0F-F259-4FFA-AC57-37B4B110744D
P2860
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@ast
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@en
type
label
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@ast
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@en
prefLabel
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@ast
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@en
P2093
P2860
P1433
P1476
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
@en
P2093
El-Rifai W
Frierson H Jr
Jackson CE
Moskaluk CA
Roviello F
Vindigni C
P2860
P2888
P304
P356
10.1038/MODPATHOL.3880416
P577
2001-10-01T00:00:00Z
P5875
P6179
1041633226